Antibody data
- Antibody Data
- Antigen structure
- References [6]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- MAB6561-100 - Provider product page
- Provider
- R&D Systems
- Product name
- Human ALCAM/CD166 Antibody
- Antibody type
- Monoclonal
- Description
- Protein A or G purified from ascites. Detects human ALCAM/CD166 in Western blots. Shows approximately 50% cross-reactivity with recombinant mouse OCAM and no cross-reactivity with recombinant human (rh) BCAM, rhEpCAM, rhMCAM, or rhNCAM-L1.
- Reactivity
- Human
- Host
- Mouse
- Conjugate
- Unconjugated
- Antigen sequence
Q13740
- Isotype
- IgG
- Antibody clone number
- 105902
- Vial size
- 100 ug
- Storage
- Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70 °C as supplied. 1 month, 2 to 8 °C under sterile conditions after reconstitution. 6 months, -20 to -70 °C under sterile conditions after reconstitution.
Submitted references Fluoxetine induces direct inhibitory effects on mesenchymal stem cell‑derived osteoprogenitor cells independent of serotonin concentration.
Alternative splicing of ALCAM enables tunable regulation of cell-cell adhesion through differential proteolysis.
Elevated ALCAM shedding in colorectal cancer correlates with poor patient outcome.
Relevance of activated leukocyte cell adhesion molecule (ALCAM) in tumor tissue and sera of cervical cancer patients.
Activated leukocyte cell adhesion molecule: a novel biomarker for breast cancer.
Phenotypic characterization of human colorectal cancer stem cells.
Koura SM, Salama M, El-Hussiny M, Khalil MEA, Lotfy A, Hassan SA, Gad Elhak SA, Sobh MA
Molecular medicine reports 2019 Apr;19(4):2611-2619
Molecular medicine reports 2019 Apr;19(4):2611-2619
Alternative splicing of ALCAM enables tunable regulation of cell-cell adhesion through differential proteolysis.
Hebron KE, Li EY, Arnold Egloff SA, von Lersner AK, Taylor C, Houkes J, Flaherty DK, Eskaros A, Stricker TP, Zijlstra A
Scientific reports 2018 Feb 16;8(1):3208
Scientific reports 2018 Feb 16;8(1):3208
Elevated ALCAM shedding in colorectal cancer correlates with poor patient outcome.
Hansen AG, Freeman TJ, Arnold SA, Starchenko A, Jones-Paris CR, Gilger MA, Washington MK, Fan KH, Shyr Y, Beauchamp RD, Zijlstra A
Cancer research 2013 May 15;73(10):2955-64
Cancer research 2013 May 15;73(10):2955-64
Relevance of activated leukocyte cell adhesion molecule (ALCAM) in tumor tissue and sera of cervical cancer patients.
Ihnen M, Kress K, Kersten JF, Kilic E, Choschzick M, Zander H, Müller V, Mahner S, Jänicke F, Woelber L, Milde-Langosch K
BMC cancer 2012 Apr 4;12:140
BMC cancer 2012 Apr 4;12:140
Activated leukocyte cell adhesion molecule: a novel biomarker for breast cancer.
Kulasingam V, Zheng Y, Soosaipillai A, Leon AE, Gion M, Diamandis EP
International journal of cancer 2009 Jul 1;125(1):9-14
International journal of cancer 2009 Jul 1;125(1):9-14
Phenotypic characterization of human colorectal cancer stem cells.
Dalerba P, Dylla SJ, Park IK, Liu R, Wang X, Cho RW, Hoey T, Gurney A, Huang EH, Simeone DM, Shelton AA, Parmiani G, Castelli C, Clarke MF
Proceedings of the National Academy of Sciences of the United States of America 2007 Jun 12;104(24):10158-63
Proceedings of the National Academy of Sciences of the United States of America 2007 Jun 12;104(24):10158-63
No comments: Submit comment
No validations: Submit validation data